drugset / Trial / NCT01734707

Atherosclerosis Monitoring and Atherogenicity Reduction Study

NCT01734707 ↗

Phase 3 Completed 300 enrolled Institute for Atherosclerosis Research, Russia
RandomizedParallel-groupDouble-blindTreatment

Summary

This study was designed to estimate the effect of two-year treatment with time-released garlic-based drug Allicor on the progression of carotid atherosclerosis in double-blinded placebo-controlled randomized clinical trial.

Timeline

Start
2004-01
Primary completion
2005-01
Completion
2005-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Allicor Traditional medicine (herbal / TCM) 150 mg Oral

Indications